BioStock studio: Xintela looks ahead

Yesterday Sven Kili, board member and CMO of Swedish company Xintela visited Biostock’s studio. Xintela works within the fields of regenerative medicine and cancer, focusing particularly...

Increased international activity within mitochondrial diseases

Receiving the diagnosis of a mitochondrial disease opens the door to lifelong suffering for patients, as such diseases still lack a cure, and as...

CLS erhåller ny order från Tyskland

I mitten av mars började Clinical Laserthermia Systems produkt TRANBERG Thermal Therapy System, för MR-ledd minimalinvasiv behandling av mjukvävnad, utvärderas för behandling av små levermetastaser av...

BioStock Studio: Scandion Oncology and Alligator Bioscience forge preclinical collaboration

Yesterday, Nils Brünner, CEO of the Danish Scandion Oncology and Per Norlén, CEO of Swedish Alligator Bioscience came together at the BioStock Studio to discuss...

BioStock Studio: Scandion Oncology pushes forward with confidence

Scandion Oncology has been very active of late, which has had significant effect on the company share. BioStock was happy to welcome CEO Nils...

Saniona’s CEO on the USD 65 million capital raise

Yesterday, Saniona communicated it had raised USD 65 million (approximately SEK 567 million) in a directed new issue to a number of US and...

BioStock Studio: Tara Heitner is ready to take Cyxone to the...

Canadian Tara Heitner took office as the new CEO of Cyxone on June 1. The company develops immunomodulating drugs for autoimmune diseases and the...

BioStock Studio: Scandion Oncology brings in New CEO

Scandion Oncology’s top candidate, SCO-101, is currently in a phase II clinical trial with metastatic colorectal cancer patients. As the study progresses, the company...

BioStock studio: Saniona’s chairman aims to recruit America’s best talents

Saniona’s primary drug candidate Tesomet is being developed to treat two severe rare disorders that currently lack specific therapeutic alternatives. On Friday, October 23, the...

BioStock Studio: Immunicum and DCprime enter immuno-oncology merger

Swedish Immunicum announced last week that it has entered into an agreement with Van Herk Investments to acquire all of the shares in DCprime, a...